The Unitary Patent System and Unified Patent Court Will Commence on 1st June – ARE YOU READY?

Spring 2023 marks the beginning of a new patent era for Europe – the UP will go into effect and UPC will be open for business. Join us in Amsterdam on 23–24 May and obtain up-to-the-minute information and strategic insights on utilizing this new patent system and optimizing your IP.

C5’s Annual Forum on Pharma & Biotech Patent Litigation in Europe has united the greatest minds of the European Life Sciences Patent Bar for over 15 years. This year is no different. We are all especially excited to welcome you to Amsterdam to mark the start of the UP and UPC paradigm.

Our esteemed 2023 faculty will ensure that you understand how the latest case law and regulatory developments will impact your cases, as well as your clients’ bottom lines. Attend and learn to navigate the latest litigation battlegrounds facing today’s pharma and biotech products.

2023 Conference Highlights include
  • Interview with Judges Rian Kalden and Margot Kokke from the UPC
  • Tactical Training Session for UPC Litigators: Developing Offensive and Defensive Strategies for Success
  • ADR in the UPC: Preparing for the New UPC Patent Mediation and Arbitration Centre (PMAC)
  • Forecast the Future of Plausibility and Priority in Light of the Latest EBA Referral Cases
  • Prepare for Anticipated Reform of the EU’s General Pharmaceutical Legislation
  • Develop Transnational Tactics for Avoiding and Defending Contributory and Induced Infringement Claims
  • Formulate Winning Global Strategies for Biosimilars and Biologics Patent Litigation
Interview with the UPC
Speaker

Honorable Rian Kalden

Senior Judge
Court of Appeal, The Hague

Speaker

Honorable Margot Kokke

Senior Judge
District Court, The Hague

Insights from Key Industry Stakeholders
Speaker

James Horgan

Assistant Managing Counsel
Merck Sharp & Dohme

Speaker

Mathilde Rauline

Head of Greater Europe Patent Litigation
Global Intellectual Property Department

Sanofi

Speaker

Karin Pramberger

Head of IP
Polpharma Group

Speaker

Ioana Ratescu

Head Legal, Regulatory Europe
Attorney at Law

Novartis Pharma AG

Speaker

Alessandra Attavino

Senior Patent Attorney
Chiesi Farmaceutici

Speaker

Dr. Sabrina Duschner

VP Patent Litigation Strategy
Fresenius Kabi Deutschland
GmbH

2023 Co-chairs
Speaker

Dominic Adair

Partner
Bristows LLP

Speaker

Bert Oosting

Partner
Hogan Lovells

Speaker

Dr. Penny Gilbert

Partner
Powell Gilbert LLP

C5’S 16 YEAR IMPACT AT PHARMA & BIOTECH EUROPE

1000+

Attendees

330+

Speakers

60+

Sponsors

36

Countries in Attendance

DISTINGUISHED FACULTY

The best that the bar, the bench, and the industry have to offer

MASTER LEVEL STRATEGIES

For litigators and in-house counsel

UNPARALLELED CONNECTIONS

With the “Who’s Who” of the European Life Sciences Patent Bar

WHO ATTENDS
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
  • Head of IP
  • Head of Patent Litigation
  • VP-Intellectual property
  • Scientific Director
  • Head of Legal / Legal Affairs
  • Principal Patent Examiner
  • Head of Global Strategy
  • Director Innovation, IP and Portfolio Management
  • R&D Patent manager
  • Associate VP & Director of Technology Licensing & Commercialization
  • Patent Counsel
Law firm attorneys with practices in:
  • Intellectual Property and Patent Law
  • Life Sciences
  • European Patent Law
  • US Patent
OUR PRIOR DELEGATES SAY IT BEST
Quote Icon

The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.

Dr. Andreas Geissler, LEUKOCARE AG
Quote Icon

Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.

Anna Lopez Lozano, ESTEVE QUÍMICA
Quote Icon

Important subject matters to discuss presented by renowned specialists. An important conference to attend.

Manuel Duraes Rocha, ABREU ADVOGADOS